Gliomatosis Cerebri
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Gliomatosis Cerebri

View Main Condition: Brain Tumor

What is the definition of Gliomatosis Cerebri?
Gliomatosis cerebri is a type of malignant (cancerous) brain tumor called a glioblastoma that develops from a specific type of brain cell called an astrocyte. It involves at least three sections (lobes) within the main part of the brain (cerebrum). It may also affect both sides of the cerebrum as well as the nerve cells within the brain (grey matter). There are two types of Gliomatosis cerebri. Type 1 (classic form) is characterized by scattered and widespread tumor cells and no apparent mass or tumor, while type 2 has similar characteristics in addition to a detectable mass or tumor. Signs and symptoms of Gliomatosis cerebri may include personality changes, memory disturbance, headaches, and seizures.
What are the alternative names for Gliomatosis Cerebri?
  • Gliomatosis cerebri
Who are the top Gliomatosis Cerebri Local Doctors?
Elite in Gliomatosis Cerebri
Elite in Gliomatosis Cerebri

Dana-Farber Cancer Institute, Center For Neuro-Oncology

450 Brookline Avenue, 
Boston, MA 
Languages Spoken:
English
Offers Telehealth

Patrick Wen is a Neurologist practicing medicine in Boston, Massachusetts. Dr. Wen is rated as an Elite provider by MediFind in the treatment of Gliomatosis Cerebri. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor. Dr. Wen is board certified in Neurology and Neuro-Oncology.

Elite in Gliomatosis Cerebri
Neurosurgery | General Surgery
Elite in Gliomatosis Cerebri
Neurosurgery | General Surgery

Brain Tumor Center

400 Parnassus Ave., Eighth Floor, 
San Francisco, CA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Dr. Mitchel S. Berger is a nationally recognized expert in treating brain and spinal cord tumors as well as tumor-related epilepsy in adults and children. He also is a specialist in brain mapping techniques – used to identify and preserve areas of motor, sensory and language function during surgery – and an expert in using the Gamma Knife, a precise, noninvasive tool that applies radiation beams for tumor treatment. He is director of the Brain Tumor Center, director of the Center for Neurological Injury and Repair and co-director of the Adult Brain Tumor Surgery Program. Berger earned his bachelor's degree from Harvard College in 1975 and his medical degree from the University of Miami Miller School of Medicine in 1979. He completed an internship and a residency at UCSF, and was awarded a clinical fellowship in neuro-oncology by the American Cancer Society and a research fellowship by the Brain Tumor Research Center. He completed further fellowship training in neuro-oncology at UCSF and in pediatric neurosurgery at the Hospital for Sick Children, an affiliate of the University of Toronto. Berger was elected to the American Association of Neurological Surgeons' board of directors and appointed to the American Board of Neurological Surgery. Dr. Berger is rated as an Elite provider by MediFind in the treatment of Gliomatosis Cerebri. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, Awake Craniotomy, and Endovascular Embolization. Dr. Berger is board certified in American Board Of Neurological Surgery, Neurological Surgery. Dr. Berger is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Gliomatosis Cerebri
Hematology Oncology | Neurology | Hematology
Elite in Gliomatosis Cerebri
Hematology Oncology | Neurology | Hematology
675 N St Clair St Ste 20-100, Galter Pavilion, 
Chicago, IL 
Experience:
39+ years
Languages Spoken:
English
Offers Telehealth

Roger Stupp is a Hematologist Oncology specialist and a Neurologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 39 years. Dr. Stupp is rated as an Elite provider by MediFind in the treatment of Gliomatosis Cerebri. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri.

What are the latest Gliomatosis Cerebri Clinical Trials?
A Trial to Evaluate Deoxyribonucleic) in BRAF (V-raf Murine Sarcoma Viral Oncogene Homolog B1)-Altered Glioma During Treatment With Plixorafenib Alone or With Retifanlimab

Summary: The investigators will evaluate the sensitivity of ctDNA from plasma and CSF at baseline (defined as C1D1) and over time in response to treatment with plixorafenib alone or in combination with retifanlimab in patients with BRAF-V600E mutant glioma refractory to prior therapies.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solution for Injection (TLX101-Tx) Plus Lomustine Versus Lomustine Alone in Patients With Radiographically Confirmed Recurrent Glioblastoma at First Recurrence (IPAX BrIGHT [IPAX-3])

Summary: This global clinical trial which evaluates the efficacy and safety of TLX101-Tx, an investigational radiopharmaceutical therapy, in combination with lomustine versus lomustine alone in adult patients with first recurrence of glioblastoma. TLX101-Tx delivers targeted radiation to glioblastoma cells. The trial is conducted in two parts: Part 1 assesses safety and radiation dosing; Part 2 is a random...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center